All-Trans-Retinoic Acid Suppresses Neointimal Hyperplasia and Inhibits Vascular Smooth Muscle Cell Proliferation and Migration via Activation of AMPK Signaling Pathway
The proliferation and migration of vascular smooth muscle cells (VSMC) is extensively involved in pathogenesis of neointimal hyperplasia. All-trans-retinoic acid (ATRA) is a natural metabolite of vitamin A. Here, we investigated the involvement of AMP-activated protein kinase (AMPK) in the anti-neoi...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-05-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.00485/full |
_version_ | 1818260473636716544 |
---|---|
author | Jingzhi Zhang Jingzhi Zhang Bo Deng Bo Deng Xiaoli Jiang Xiaoli Jiang Min Cai Min Cai Ningning Liu Shuangwei Zhang Shuangwei Zhang Yongzhen Tan Guiqiong Huang Wen Jin Bin Liu Bin Liu Shiming Liu |
author_facet | Jingzhi Zhang Jingzhi Zhang Bo Deng Bo Deng Xiaoli Jiang Xiaoli Jiang Min Cai Min Cai Ningning Liu Shuangwei Zhang Shuangwei Zhang Yongzhen Tan Guiqiong Huang Wen Jin Bin Liu Bin Liu Shiming Liu |
author_sort | Jingzhi Zhang |
collection | DOAJ |
description | The proliferation and migration of vascular smooth muscle cells (VSMC) is extensively involved in pathogenesis of neointimal hyperplasia. All-trans-retinoic acid (ATRA) is a natural metabolite of vitamin A. Here, we investigated the involvement of AMP-activated protein kinase (AMPK) in the anti-neointimal hyperplasia effects of ATRA. We found that treatment with ATRA significantly reduced neointimal hyperplasia in the left common carotid artery ligation mouse model. ATRA reduced the proliferation and migration of VSMC, A7r5 and HASMC cell lines. Our results also demonstrated that ATRA altered the expression of proliferation-related proteins, including CyclinD1, CyclinD3, CyclinA2, CDK2, CDK4, and CDK6 in VSMC. ATRA dose-dependently enhanced the phosphorylation level of AMPKα (Thr172) in the left common carotid artery of experimental mice. Also, the phosphorylation level of AMPKα in A7r5 and HASMC was significantly increased. In addition, ATRA dose-dependently reduced the phosphorylation levels of mTOR and mTOR target proteins p70 S6 kinase (p70S6K) and 4E-binding protein 1 (4EBP1) in A7r5 and HASMC. Notably, the inhibition of AMPKα by AMPK inhibitor (compound C) negated the protective effect of ATRA on VSMC proliferation in A7r5. Also, knockdown of AMPKα by siRNA partly abolished the anti-proliferative and anti-migratory effects of ATRA in HASMC. Molecular docking analysis showed that ATRA could dock to the agonist binding site of AMPK, and the binding energy between AMPK and ATRA was -7.91 kcal/mol. Molecular dynamics simulations showed that the binding of AMPK-ATRA was stable. These data demonstrated that ATRA might inhibit neointimal hyperplasia and suppress VSMC proliferation and migration by direct activation of AMPK and inhibition of mTOR signaling. |
first_indexed | 2024-12-12T18:31:54Z |
format | Article |
id | doaj.art-56f839088b404cc79ae01a44c572daef |
institution | Directory Open Access Journal |
issn | 1663-9812 |
language | English |
last_indexed | 2024-12-12T18:31:54Z |
publishDate | 2019-05-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Pharmacology |
spelling | doaj.art-56f839088b404cc79ae01a44c572daef2022-12-22T00:15:55ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122019-05-011010.3389/fphar.2019.00485433471All-Trans-Retinoic Acid Suppresses Neointimal Hyperplasia and Inhibits Vascular Smooth Muscle Cell Proliferation and Migration via Activation of AMPK Signaling PathwayJingzhi Zhang0Jingzhi Zhang1Bo Deng2Bo Deng3Xiaoli Jiang4Xiaoli Jiang5Min Cai6Min Cai7Ningning Liu8Shuangwei Zhang9Shuangwei Zhang10Yongzhen Tan11Guiqiong Huang12Wen Jin13Bin Liu14Bin Liu15Shiming Liu16Guangzhou Institute of Cardiovascular Disease, Guangdong Key Laboratory of Vascular Diseases, State Key Laboratory of Respiratory Disease, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaDepartment of Traditional Chinese Medicine, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaGuangzhou Institute of Cardiovascular Disease, Guangdong Key Laboratory of Vascular Diseases, State Key Laboratory of Respiratory Disease, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaDepartment of Traditional Chinese Medicine, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaGuangzhou Institute of Cardiovascular Disease, Guangdong Key Laboratory of Vascular Diseases, State Key Laboratory of Respiratory Disease, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaDepartment of Traditional Chinese Medicine, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaGuangzhou Institute of Cardiovascular Disease, Guangdong Key Laboratory of Vascular Diseases, State Key Laboratory of Respiratory Disease, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaDepartment of Traditional Chinese Medicine, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaGuangzhou Institute of Cardiovascular Disease, Guangdong Key Laboratory of Vascular Diseases, State Key Laboratory of Respiratory Disease, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaGuangzhou Institute of Cardiovascular Disease, Guangdong Key Laboratory of Vascular Diseases, State Key Laboratory of Respiratory Disease, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaDepartment of Traditional Chinese Medicine, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaDepartment of Traditional Chinese Medicine, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaDepartment of Internal Medicine, Huizhou Hospital of Traditional Chinese Medicine, Huizhou, ChinaDepartment of Cardiology, Guangdong Second Provincial General Hospital, Guangzhou, ChinaGuangzhou Institute of Cardiovascular Disease, Guangdong Key Laboratory of Vascular Diseases, State Key Laboratory of Respiratory Disease, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaDepartment of Traditional Chinese Medicine, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaGuangzhou Institute of Cardiovascular Disease, Guangdong Key Laboratory of Vascular Diseases, State Key Laboratory of Respiratory Disease, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaThe proliferation and migration of vascular smooth muscle cells (VSMC) is extensively involved in pathogenesis of neointimal hyperplasia. All-trans-retinoic acid (ATRA) is a natural metabolite of vitamin A. Here, we investigated the involvement of AMP-activated protein kinase (AMPK) in the anti-neointimal hyperplasia effects of ATRA. We found that treatment with ATRA significantly reduced neointimal hyperplasia in the left common carotid artery ligation mouse model. ATRA reduced the proliferation and migration of VSMC, A7r5 and HASMC cell lines. Our results also demonstrated that ATRA altered the expression of proliferation-related proteins, including CyclinD1, CyclinD3, CyclinA2, CDK2, CDK4, and CDK6 in VSMC. ATRA dose-dependently enhanced the phosphorylation level of AMPKα (Thr172) in the left common carotid artery of experimental mice. Also, the phosphorylation level of AMPKα in A7r5 and HASMC was significantly increased. In addition, ATRA dose-dependently reduced the phosphorylation levels of mTOR and mTOR target proteins p70 S6 kinase (p70S6K) and 4E-binding protein 1 (4EBP1) in A7r5 and HASMC. Notably, the inhibition of AMPKα by AMPK inhibitor (compound C) negated the protective effect of ATRA on VSMC proliferation in A7r5. Also, knockdown of AMPKα by siRNA partly abolished the anti-proliferative and anti-migratory effects of ATRA in HASMC. Molecular docking analysis showed that ATRA could dock to the agonist binding site of AMPK, and the binding energy between AMPK and ATRA was -7.91 kcal/mol. Molecular dynamics simulations showed that the binding of AMPK-ATRA was stable. These data demonstrated that ATRA might inhibit neointimal hyperplasia and suppress VSMC proliferation and migration by direct activation of AMPK and inhibition of mTOR signaling.https://www.frontiersin.org/article/10.3389/fphar.2019.00485/fullall-trans-retinoic acidneointimal hyperplasiavascular smooth muscle cellproliferationAMP-activated protein kinase |
spellingShingle | Jingzhi Zhang Jingzhi Zhang Bo Deng Bo Deng Xiaoli Jiang Xiaoli Jiang Min Cai Min Cai Ningning Liu Shuangwei Zhang Shuangwei Zhang Yongzhen Tan Guiqiong Huang Wen Jin Bin Liu Bin Liu Shiming Liu All-Trans-Retinoic Acid Suppresses Neointimal Hyperplasia and Inhibits Vascular Smooth Muscle Cell Proliferation and Migration via Activation of AMPK Signaling Pathway Frontiers in Pharmacology all-trans-retinoic acid neointimal hyperplasia vascular smooth muscle cell proliferation AMP-activated protein kinase |
title | All-Trans-Retinoic Acid Suppresses Neointimal Hyperplasia and Inhibits Vascular Smooth Muscle Cell Proliferation and Migration via Activation of AMPK Signaling Pathway |
title_full | All-Trans-Retinoic Acid Suppresses Neointimal Hyperplasia and Inhibits Vascular Smooth Muscle Cell Proliferation and Migration via Activation of AMPK Signaling Pathway |
title_fullStr | All-Trans-Retinoic Acid Suppresses Neointimal Hyperplasia and Inhibits Vascular Smooth Muscle Cell Proliferation and Migration via Activation of AMPK Signaling Pathway |
title_full_unstemmed | All-Trans-Retinoic Acid Suppresses Neointimal Hyperplasia and Inhibits Vascular Smooth Muscle Cell Proliferation and Migration via Activation of AMPK Signaling Pathway |
title_short | All-Trans-Retinoic Acid Suppresses Neointimal Hyperplasia and Inhibits Vascular Smooth Muscle Cell Proliferation and Migration via Activation of AMPK Signaling Pathway |
title_sort | all trans retinoic acid suppresses neointimal hyperplasia and inhibits vascular smooth muscle cell proliferation and migration via activation of ampk signaling pathway |
topic | all-trans-retinoic acid neointimal hyperplasia vascular smooth muscle cell proliferation AMP-activated protein kinase |
url | https://www.frontiersin.org/article/10.3389/fphar.2019.00485/full |
work_keys_str_mv | AT jingzhizhang alltransretinoicacidsuppressesneointimalhyperplasiaandinhibitsvascularsmoothmusclecellproliferationandmigrationviaactivationofampksignalingpathway AT jingzhizhang alltransretinoicacidsuppressesneointimalhyperplasiaandinhibitsvascularsmoothmusclecellproliferationandmigrationviaactivationofampksignalingpathway AT bodeng alltransretinoicacidsuppressesneointimalhyperplasiaandinhibitsvascularsmoothmusclecellproliferationandmigrationviaactivationofampksignalingpathway AT bodeng alltransretinoicacidsuppressesneointimalhyperplasiaandinhibitsvascularsmoothmusclecellproliferationandmigrationviaactivationofampksignalingpathway AT xiaolijiang alltransretinoicacidsuppressesneointimalhyperplasiaandinhibitsvascularsmoothmusclecellproliferationandmigrationviaactivationofampksignalingpathway AT xiaolijiang alltransretinoicacidsuppressesneointimalhyperplasiaandinhibitsvascularsmoothmusclecellproliferationandmigrationviaactivationofampksignalingpathway AT mincai alltransretinoicacidsuppressesneointimalhyperplasiaandinhibitsvascularsmoothmusclecellproliferationandmigrationviaactivationofampksignalingpathway AT mincai alltransretinoicacidsuppressesneointimalhyperplasiaandinhibitsvascularsmoothmusclecellproliferationandmigrationviaactivationofampksignalingpathway AT ningningliu alltransretinoicacidsuppressesneointimalhyperplasiaandinhibitsvascularsmoothmusclecellproliferationandmigrationviaactivationofampksignalingpathway AT shuangweizhang alltransretinoicacidsuppressesneointimalhyperplasiaandinhibitsvascularsmoothmusclecellproliferationandmigrationviaactivationofampksignalingpathway AT shuangweizhang alltransretinoicacidsuppressesneointimalhyperplasiaandinhibitsvascularsmoothmusclecellproliferationandmigrationviaactivationofampksignalingpathway AT yongzhentan alltransretinoicacidsuppressesneointimalhyperplasiaandinhibitsvascularsmoothmusclecellproliferationandmigrationviaactivationofampksignalingpathway AT guiqionghuang alltransretinoicacidsuppressesneointimalhyperplasiaandinhibitsvascularsmoothmusclecellproliferationandmigrationviaactivationofampksignalingpathway AT wenjin alltransretinoicacidsuppressesneointimalhyperplasiaandinhibitsvascularsmoothmusclecellproliferationandmigrationviaactivationofampksignalingpathway AT binliu alltransretinoicacidsuppressesneointimalhyperplasiaandinhibitsvascularsmoothmusclecellproliferationandmigrationviaactivationofampksignalingpathway AT binliu alltransretinoicacidsuppressesneointimalhyperplasiaandinhibitsvascularsmoothmusclecellproliferationandmigrationviaactivationofampksignalingpathway AT shimingliu alltransretinoicacidsuppressesneointimalhyperplasiaandinhibitsvascularsmoothmusclecellproliferationandmigrationviaactivationofampksignalingpathway |